journal
https://read.qxmd.com/read/38566825/outcomes-of-pediatric-extracranial-germ-cell-tumors-a-single-center-experience-in-a-developing-country
#1
JOURNAL ARTICLE
Symbat Saliyeva, Riza Boranbayeva, Minira Bulegenova, Bakhram Zhumadullayev, Gaukhar Nurzhanova, Lyazat Manzhuova
The purpose of this study was to analyze the outcomes of extracranial GCT in children in a developing country and to assess prognostic factors. The data on 141 children (<18 years old) with extracranial GCT, confirmed histopathologically, collected over the past 9 years (from February 2013 to June 2022) were retrospectively studied. The patients underwent the same therapy with platinum-containing chemotherapy regimens. In the malignant GCT group, OS and EFS were 81.0 ± 4% and 73 ± 5%, respectively...
2024: Rare Tumors
https://read.qxmd.com/read/38559436/ewing-s-sarcoma-of-the-parotid-gland-a-rare-entity-with-review-of-the-literature
#2
Hayfa Chahdoura, Alia Mousli, Ghaiet El Fidaa Noubigh, Safia Yahyaoui, Rim Abidi, Nasr Chiraz
BACKGROUND: Ewing's sarcoma is a rare malignant entity. Extraosseous Ewing's sarcoma (EES) of the head and neck region is a rare occurrence, and Ewing's sarcoma of the parotid gland is even rarer. To the best of our knowledge, we reported the first case of extraskeletal ES originating from the parotid gland in the Tunisian literature. CASE REPORT: We report a rare case of EES of the parotid gland in a 35-year-old female. She presented with left parotid tumefaction...
2024: Rare Tumors
https://read.qxmd.com/read/38550523/spindle-cell-carcinomaof-the-larynx-a-case-report-and-literature-review
#3
Alia Mousli, Ferdaous Friaa, Emna Boudhina, Selma Kamoun, Rim Abidi, Chiraz Nasr
INTRODUCTION: Spindle cell carcinoma (SCC), also called sarcomatoid carcinoma or carcinosarcoma, represents a rare variant of squamous cell carcinoma that may involve multiple organs, including the larynx. It is a mixed tumor, composed of both malignant epithelial and mesenchymal elements. As the larynx appears to be an unusual site, we report a case of treated SCC laryngeal as well as a literature review of such tumor. OBSERVATION: A 72-year-old male, with 2 months' history of a progressive worsening dysphonia, was examined...
2024: Rare Tumors
https://read.qxmd.com/read/38550522/extra-gastrointestinal-stromal-tumour-of-the-lesser-omentum-presenting-as-a-massive-intra-abdominal-swelling-a-case-report-and-literature-review
#4
John Adi Ashindoitiang, Victor Ikechukwu Canice Nwagbara, Theophilus Ipeh Ugbem, Nkami Joseph Enya, Ikechimka Ogbugbanduchi Aniebo, Joseph Christopher Ekong, Sidney Esotu Obinna, Maurice Efana Asuquo
Extra gastrointestinal stromal tumour(EGIST) is rare and is regarded as gastrointestinal stromal tumour(GIST) that originates outside of the gastrointestinal tract. They originate from other intraabdominal tissues such as the omentum, mesentery and peritoneum. The cell of origin is the interstitial cell of Cajal(ICC), a pacemaker cell that controls gastrointestinal peristalsis and the tumor is characterized by the expression of KIT(CD117) a transmembrane tyrosine kinase receptor. Here, a 49-year-old female who presented with a 6 month history of abdominal pain, progressive abdominal swelling and the presence of an upper abdominal mass...
2024: Rare Tumors
https://read.qxmd.com/read/38525087/low-grade-mucoepidermoid-carcinoma-mimicking-benign-cystic-lesions-in-the-salivary-gland-a-diagnostic-dilemma
#5
Wangpan Shi, Timothy Law, Kevin Thomas Brumund, Jennifer Chang, Charmi Patel, Grace Lin, Jingjing Hu
Mucoepidermoid carcinoma (MEC) is a common malignancy arising in the parotid gland. The diagnosis of MEC is typically based on its morphological features alone, characteristically containing mucocytes, intermediate cells and epidermoid cells. However, when cystic degeneration is diffuse, it is challenging to distinguish MEC from other benign cystic tumors. This is a case report of a 58-year-old Caucasian man who presented with a parotid mass. H&E sections of the mass reveal multiloculated cysts lined by bland-looking epithelium with only rare papillary architectures...
2024: Rare Tumors
https://read.qxmd.com/read/38525086/retroperitoneal-mixed-neuroendocrine-non-neuroendocrine-neoplasm-a-case-report-and-review-of-literature
#6
John Adi Ashindoitiang, Victor Ikechukwu Canice Nwagbara, Theophilus Ugbem Ipeh, Ben Chukwu, Henry Olaleye Obanife, Alfred Ottoh Eyong, Maurice Efana Asuquo
The existence of both neuroendocrine and non-neuroendocrine histology in variable proportion in a lesion has been described by the World Health Organisation (WHO) as mixed neuroendocrine and non-neuroendocrine neoplasm (MiNEN). The pathogenesis of this tumour remains controversial but molecular studies point towards a common monoclonal origin. Tumours are classified as functioning and nonfunctioning based on substances secreted. The nonfunctioning tumours may be discovered due to its local effect. Presented is a 66-year-old male with an intra-abdominal mass, underwent laparotomy and excision biopsy with transient right lower limb lymphoedema...
2024: Rare Tumors
https://read.qxmd.com/read/38435384/primary-lung-low-grade-fibromyxoid-sarcoma-a-rare-case-with-a-diagnostic-dilemma
#7
Aida Ayadi, Yoldez Houcine, Chirine Moussa, Houda Rouis, Tarek Abid, Begueret Hugues, François Le Loarer
Low-grade fibromyxoid sarcoma (LGFMS) is a rare, low-grade malignant soft tissue tumor that is often mistaken for benign or more rarely malignant tumor types. Commonly, this tumor affects young adults and typically arises in the deep proximal extremities or trunk with frequent recurrences and can metastasize to the lungs many years late. Visceral LGFMS is extremely rare. Only a few cases of primary LGFMS of the lung have been reported. Here, we present the clinical, gross, microscopic, and immunohistochemical characteristics of Evans tumor occurring in the lung with a review of the literature and discuss the differential diagnosis in this exceptional localization...
2024: Rare Tumors
https://read.qxmd.com/read/38371427/dermatofibrosarcoma-protuberans-case-series-in-a-tropical-setting-and-review-of-literature
#8
John Adi Ashindoitiang, Victor Ikechukwu Canice Nwagbara, Ugbem Theophilus Ipeh, George Peter Owusu, Maurice Efana Asuquo
Dermatofibrosarcoma protuberans (DFSP) is an infrequent cutaneous tumour that may involve subcutaneous fat and in some cases fascia, muscles and bone. The infrequent occurrence lessens its clinical awareness in addition to its clinical semblance to many common cutaneous lesions. It is characterized by proclivity for local recurrence. We evaluated the clinical presentation and treatment outcomes of six consecutive cases of DFSP with histologic diagnosis in the University of Calabar Teaching Hospital, Calabar seen between January 2013 and December 2022...
2024: Rare Tumors
https://read.qxmd.com/read/38371426/real-world-evidence-for-ultra-rare-cancers
#9
JOURNAL ARTICLE
Leonidas Mavroeidis, Andrea Napolitano, Paul Huang, Robin L Jones
No abstract text is available yet for this article.
2024: Rare Tumors
https://read.qxmd.com/read/38074447/an-extremely-rare-case-of-recurrent-pleomorphic-myxoidliposarcoma-with-response-to-eribulin-chemotherapy-a-case-report
#10
Raghavendra Rao, Sameer Rastogi, Divya Kashyap, Shamim A Shamim, Adarsh Barwad
Pleomorphic myxoid liposarcoma (PML) is a newly recognized entity with aggressive clinical behavior and a tendency to recur. It has histological features of both myxoid and pleomorphic liposarcoma and lacks the molecular and structural chromosomal abnormalities associated with myxoid and pleomorphic liposarcoma. The data about their response to chemotherapy is quite sparse. We report a case of incidentally detected pleomorphic myxoid liposarcoma of the mediastinum in a 32-year-old gentleman. After resection and adjuvant chemotherapy with doxorubicin and ifosfamide, there was no evidence of residual disease at the end of treatment...
2023: Rare Tumors
https://read.qxmd.com/read/38023658/talquetamab-a-promising-immunotherapy-for-multiple-myeloma
#11
JOURNAL ARTICLE
Amna Tariq, Abdul Wahid, Fatima Asif, Mahnoor Khan
No abstract text is available yet for this article.
2023: Rare Tumors
https://read.qxmd.com/read/38023657/letter-re-uveal-melanoma-metastasis-to-the-liver-unveiling-effective-strategies-with-hepzato-kit
#12
JOURNAL ARTICLE
Ushna Zameer, Wajiha Shaikh, Anood Choudhary
No abstract text is available yet for this article.
2023: Rare Tumors
https://read.qxmd.com/read/37909028/follicular-adenoma-with-bizarre-nuclei-and-wild-type-p53-expression-a-case-report-and-literature-review
#13
Daniel Nguyen, Nyein Nyein Htun, Beverly Wang
INTRODUCTION: Thyroid cancer is the most common endocrine tumor in humans. Follicular adenoma/carcinoma is the second most common subtype. Multiple histological patterns have been identified. Follicular adenoma with bizarre nuclei is one of the patterns associated with p53 mutation and has an unclear clinical prognosis. CASE REPORT: A 74-year-old female presented with incidental findings of elevated TSH levels and normal thyroid markers. Ultrasound was performed and revealed multiple bilateral thyroid nodules measuring up to 1...
2023: Rare Tumors
https://read.qxmd.com/read/37840703/elrexfio%C3%A2-elranatamab-bcmm-the-game-changer-in-treatment-of-multiple-myeloma
#14
JOURNAL ARTICLE
Taruba Rais, Afsheen Khan, Rumaisa Riaz
Multiple myeloma is the second most common plasma cell malignancy, characterized by uncontrolled proliferation of plasma cells within the bone marrow. ELREXFIO™ (elranatamab-bcmm) is a recently FDA-approved drug for relapsed and refractory multiple myeloma. The progression of multiple myeloma involves interactions with various bone marrow cell types, and targeting this microenvironment has shown promising results in inhibiting its growth and osteolysis. ELREXFIO, a bispecific antibody targeting CD3 and BCMA, activates cytotoxic T-lymphocyte responses against BCMA-expressing myeloma cells...
2023: Rare Tumors
https://read.qxmd.com/read/37780814/-a-beacon-of-hope-for-relapsed-multiple-myeloma-patients-talvey%C3%A2
#15
JOURNAL ARTICLE
Nawal Khaliq, Rumaisa Riaz, Aleeza Hasan, Sara Alauddin
No abstract text is available yet for this article.
2023: Rare Tumors
https://read.qxmd.com/read/37767464/advancing-precision-oncology-in-metastatic-colorectal-cancer-the-food-and-drug-administration-approval-of-foundation-one-liquid-cdx-as-a-companion-diagnostic-a-correspondence
#16
JOURNAL ARTICLE
Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan
No abstract text is available yet for this article.
2023: Rare Tumors
https://read.qxmd.com/read/37743905/teratocarcinosarcoma-of-the-head-and-neck-clinicopathologic-review-of-a-rare-entity
#17
REVIEW
Rana S Al-Zaidi
Teratocarcinosarcoma is a rare, highly aggressive malignancy of the head and neck, characterized by multiphenotypic and triphasic growth of epithelial, mesenchymal, and primitive neuroepithelial elements. Owing to its rarity and morphological heterogeneity, as well as the lack of experience with this neoplasm, teratocarcinosarcoma is often misdiagnosed, particularly in small biopsy samples when only some of the elements are identified, thus leading to delayed management. Aggressive clinical behavior and poor survival outcomes, necessitate an accurate diagnosis and appropriate treatment...
2023: Rare Tumors
https://read.qxmd.com/read/37743904/the-enigmatic-ear-unveiling-a-rare-case-of-a-primary-cutaneous-cd8-acral-t-cell-lymphoproliferative-disorder-with-a-literature-review
#18
Ghada Sahraoui, Farah Sassi, Lamia Charfi, Raoudha Doghri, Karima Mrad
Introduction: Primary cutaneous CD8+ acral T-cell lymphoproliferative disorder (CD8+ ATCLPD) is a rare form of cutaneous T-cell lymphoma that commonly presents on the acral regions of the body. We report a case of a 61-year-old man diagnosed with primary cutaneous CD8+ ATCLPD of the ear. Case presentation: A 61-year-old man presented with a non-healing, erythematous painful macule on the ear that had been evolving for the past 3 months. The lesion was resected, and histopathological examination revealed a primary cutaneous CD8+ ATCLPD with acral localization...
2023: Rare Tumors
https://read.qxmd.com/read/37601701/vorasidenib-a-promising-therapeutic-breakthrough-for-diffuse-isocitrate-dehydrogenase-mutant-gliomas
#19
JOURNAL ARTICLE
Abdul Wahid, Amna Tariq, Faiza Ahsan, Fatima Asif
No abstract text is available yet for this article.
2023: Rare Tumors
https://read.qxmd.com/read/37534337/epcoritamab-bysp-epkinly-a-phenomenal-breakthrough-in-the-treatment-of-diffuse-large-b-cell-lymphoma
#20
JOURNAL ARTICLE
Rumaisa Riaz, Afsheen Khan, Tasmiyah Siddiqui
No abstract text is available yet for this article.
2023: Rare Tumors
journal
journal
42932
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.